All News
EULAR 2022 – Day 3 Report
By now, those of us attending the meeting know how to find a free coffee or sprite, have found comfortable meeting nooks and know our way around! PAnd congrats to you virtual Rheums for mastering the multi-screen, multitask simultaneous consumption posters, tweets and oral abstract presentations.
Read Article
What drives residual pain improvement in #JAKi treated pts? Dunno but #Baricitinib and #Sarilimab showed better pain decrease vs placebo and #Adalimumab. #OP0052 showed both #Tofacitinib & Adalimumab reduced pain more than placebo in PsA & RA if in remission @RheumNow @eular_org
Janet Pope Janetbirdope ( View Tweet)
Mease et al. IL23i guselkumab on axial outcomes in PsA at 2 years in DISCOVER-2. Guselkumab improves BASDAI, mBASDAI, spinal pain, ASDAS to week 100. Still trying to get my head around this seeming to work for PsA spinal disease but not axSpA @RheumNow #EULAR2022 POS1037 https://t.co/LZgXEl6Ohl
Richard Conway RichardPAConway ( View Tweet)
Babies! Safety and Outcomes Data on Pregnancies
#EULAR2022 highlighted several posters on pregnancy, an important subject as most rheumatic diseases afflicts women during their childbearing years. I wanted to share with you the ones that caught my eye...
https://t.co/ulQIo2gdlO https://t.co/dpoMd5Wbah
Links:
Dr. John Cush RheumNow ( View Tweet)
Getting Real on PMR
Dr. David Liew talks polymyalgia rheumatica and how our understanding has evolved over the years. #EULAR2022
https://t.co/BCdOTzeOHx https://t.co/VO95uHaKxg
Links:
Dr. John Cush RheumNow ( View Tweet)
Full circle. I met Prof D Isenberg at my first EULAR Congress 10 years ago. He welcomed a strangers request to come for Rheumatology training at UCLH with open arms. A kind, generous soul. My heart is full whenever we meet.❤️ https://t.co/yvwYyDKRD6
Dzifa Dey RheumtoBloom ( View Tweet)
Looks like I’m not the only one who doesn’t let the absence of synovitis stop me from sometimes treating high-risk clinically suspect arthralgias i.e. ‘very early early RA’
The truth comes out in anonymous surveys!
#EULAR2022 @RheumNow https://t.co/BqTLy4HBWR
David Liew drdavidliew ( View Tweet)
A bit late but finally managed to get a proper Danish pastries on Day 3 in 🇩🇰🥳 #EULARpastrychallenge 🥐 #EULAR2022 https://t.co/PhmOd3ylzb
Md Yuzaiful Md Yusof Yuz6Yusof ( View Tweet)
Interesting stats - over 4400 #EULAR2022 tweets yesterday but only half that number today. #ConferenceFatigue @RheumNow https://t.co/HILdrb5Wkd
TheDaoIndex KDAO2011 ( View Tweet)
#OP0279 #EULAR2022 Let's start with N=5! Promising new therapy CAR T-cell in #lupus. All patients were refractory to various therapies and had active nephritis. Post-treatment, all responded clinically and serologically! Need to go to RCT next @RheumNow https://t.co/RaTlVALQqn
Md Yuzaiful Md Yusof Yuz6Yusof ( View Tweet)
Difficult to Treat RA (D2TRA): Jacob van Laar
#EULAR2022 Points to consider @RheumNow
1. Consider the diagnosis! Misdiagnosis or mimic?
2. U/s when in doubt
3. Caution in comorbidities (obesity, fm) which can overestimate inflamm markers, disease activity https://t.co/YT9NRv7EA0
Eric Dein ericdeinmd ( View Tweet)
@eular_org Systematic Literature Review #workstatus in #RMDs
vs. general pop.
% manuscrits describing worse outcomes:
-unemployment 67%
-work disability/stop work
91%
-absenteeism 92%
Time to collaborate w/ policy makers to reduce employment gap!
#EULAR2022 @RheumNow
POS0160
Aurelie Najm AurelieRheumo ( View Tweet)
After linking ultra-processed food with developing autoimmune disease in at-risk individuals, we clarified:
What is an ultra-processed food?
has undergone mechanic or enzymatic processing
Not all bread is the same.
Dietary surveys fail on this.
Joao Sabino #EULAR2022 @RheumNow https://t.co/RIRagCe4nd
David Liew drdavidliew ( View Tweet)
Does diet drive IL-23 in IBD and PsA? Perhaps if you have the right baseline risk. The science is evolving quickly
Stronger rationale that diet may be really important in some patients
#EULAR2022 #IL23 @RheumNow https://t.co/hV54PvfOXV
David Liew drdavidliew ( View Tweet)
Incidentally looked at the FLORA study in @RheumNow Tuesday Night Rheumatology for ‘PsA All The Way’, a month before #EULAR2022
https://t.co/s5qa4breCf
https://t.co/a52myvJMMc
David Liew drdavidliew ( View Tweet)
Watch: AURORA-2 Two-year Results Voclosporin For Lupus Nephritis
https://t.co/k61KOBXRSl
#EULAR2022 https://t.co/Q7cjqvQyFG
Links:
Dr. John Cush RheumNow ( View Tweet)
“Modify medications, work on lifestyle (weight loss/exercise), and emphasize patience.”
- Prof van Lear on managing difficult to treat RA
#EULAR2022 @rheumnow
TheDaoIndex KDAO2011 ( View Tweet)
#COVID19 #pandemic has affected #rheumatology training
Negative impact on
▶️Learning
▶️Research
▶️Mental health
▶️Physical health
👉🏽https://t.co/Irtkg8TjZt
By @kristenyoung @SuAnnYeoh1 @EBRheum @SattuiSEMD @RichardPAConway @SituationRheum @KilianMD @rheum_covid et al @RheumJnl https://t.co/wysWzE92Fm
Dr Ai Lyn Tan DrAiLynTan ( View Tweet)
These findings suggest a pathogenic link between airway inflammation in bronchiectasis and RA-related autoantibodies
Jeffrey Sparks MD MMSc jeffsparks ( View Tweet)
controls were n=360. typo
Jeffrey Sparks MD MMSc jeffsparks ( View Tweet)